Trials / Completed
CompletedNCT04655326
Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
Assessment of Customized Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 296 (actual)
- Sponsor
- Arizona State University · Academic / Other
- Sex
- All
- Age
- 30 Months – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.
Detailed description
SunGenomics provides its customers with a customized probiotic based on an analysis of the microbiota in their stool samples. Customers who have autism spectrum disorders are invited to participate in this study by completing several questionnaires about their medical history, diet, autism symptoms, and gastrointestinal symptoms before taking the probiotic, and to repeat those questionnaires approximately 3 months later. This is effectively an open-label study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Flore | personalized blend of GRAS approved probiotic strains, prebiotics, and botanicals |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2025-05-15
- Completion
- 2025-07-12
- First posted
- 2020-12-07
- Last updated
- 2026-04-09
- Results posted
- 2026-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04655326. Inclusion in this directory is not an endorsement.